DatasetName,KDM3B_S(1253) KDM3B_S(1265) KDM3B_S(1284) KDM3B_S(1299) KDM3B_S(252) KDM3B_S(263) KDM3B_S(288) KDM3B_S(289) KDM3B_S(311) KDM3B_S(314) KDM3B_S(320) KDM3B_S(583) KDM3B_S(629) KDM3B_S(647) KDM3B_S(718) KDM3B_S(725) KDM3B_S(744) KDM3B_S(779) KDM3B_S(784) KDM3B_S(852) KDM3B_T(1282) KDM3B_T(270) KDM3B_T(614) KDM3B_T(740) KDM3B_T(751),KDM3B_S(1227) KDM3B_S(1251) KDM3B_S(1267) KDM3B_S(1331) KDM3B_S(278) KDM3B_S(295) KDM3B_S(563) KDM3B_S(772) KDM3B_S(773) KDM3B_S(778) KDM3B_S(798) KDM3B_S(822) KDM3B_T(1270) KDM3B_T(1307)
RM2024_Intensity D4-1___3,,
RB2022_4_PostEndurance,,
FSO2013_Ratio M/L normalized Rep3,0.5604148073465953,0.4479587791658649
SR2019_MCF7_Biol_repl_3,,
RKK2015_IKKb(K44M)+TNF-α/IKKb(K44M),,
SR2019_LM2_Biol_repl_1,,
RCJD2014_15min_1,,
AS2011_Ratio H/L Normalized by Proteins Inhi_1,,
CK2022_7 16-1,0.5502087352463549,0.41999963207225843
NJH2025_Sub12_HIIT_Mid,,
AH2018_LFQ_IT_1_C,0.556412225645762,
RKK2015_TNF-α/basal,0.5575589588028331,
JJ2018_Ratio H/M normalized pP2,,
NJH2025_Sub12_MICT_Pre,,
NJH2025_Sub7_MICT_Post,,
DL2023_control-3,,
ZX2022_Control Replicate 2,0.5567515694020617,0.4375151321224263
HS2024_6_B_T3,0.55465015282574,0.43993557627920526
JW2015_Intensity pre1,,
IMM2018_normalised rep. int. Empty-3,,
AMK2021_30R_p5,,
FSO2013_Ratio M/L normalized Rep1,0.5528257749401336,0.418539065891644
SR2019_MDAMB231_Biol_repl_4,,
GF2025_P2_Sph,0.5520086718220327,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt2b,,
NJH2025_Sub13_HIIT_Mid,,
CP2009_Ratio M/L,,
NJH2025_Sub7_HIIT_Post,,
KBE2022_Log2_Ex_44_T,0.5552401823930722,0.4281603626316247
DB2022_Intensity L2,,
TM2022_mock.4h.C,,
AST2020_anti-CD3.2,,
CW2012_10 µM Erl/control Experiment 1 Replicate B,,
HS2024_7_B_N1,0.5564464688632935,0.43415077222434345
FSO2013_Ratio M/L normalized Rep1___1,0.5528734145545494,0.41859050880619053
SAS2015_AZD/DMSO_Exp3,0.5623965987679198,
RM2024_Intensity D0-2___3,,
RM2024_Intensity D6-1,,
RB2022_8_RecoverySprint,,
RB2022_5_PreEndurance,,
CKC2017_log2 normalized phosphoproteomics_30min_rep#2,,
EP2017_Untreated R#4 normalized log2 ratio,0.5165357556887697,0.43474991299212135
WZ2023_Pu_010_30min,0.5484338421438241,0.42266262220393963
AS2011_Ratio H/L Proteins RNAi_2,,
RB2022_4_PreStrength,,
NJH2024_Sub4_MICT_Post,,
AH2018_LFQ_M_1_X,0.5492442516883259,
RB2022_8_RecoveryEndurance,,
KBE2022_Log2_Ex_14_U,0.552840631996061,0.4277281477751558
FSO2013_Ratio M/L normalized Rep3___3,,
AH2018_TMTMS3_1_C,0.5516628423813782,
JJ2018_Ratio H/L normalized___1,,
ZQ2022_C2,,0.44382745678178875
RB2022_5_PreSprint,,
PG2020_Intensity 8h_C,,0.432748775494818
AH2018_SILAC_MR_2_N,,
MV2014_Ratio M/L normalized A1___2 (2 min),,
TM2022_S2.8h.B,,
MV2014_Ratio M/H normalized B3___1 (30 min),,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as4a,,
RNJ2017_Log2_ratio_Tsup:Tstim_D2,,
RM2024_Intensity D6-1___2,,
NJH2025_Sub7_MICT_Mid,,
LY2019_P1+,,0.4401598004217599
AS2011_Ratio H/L Proteins Inhi_2,,
BS2014_Log2(Ratio H/L normalized),,
UK2020_HCM_2,,
FSO2013_Ratio H/L normalized Rep2___2,0.553677952350818,0.42168996876020115
EP2017_Pervanadate R#3 normalized log2 ratio,0.5675838423345779,0.4347857764678381
RM2024_Intensity D4-3___3,,
RB2022_5_PreStrength,,
NJH2024_Sub4_MICT_Mid,,
TM2022_S2.4h.A,,
RB2022_5_PostStrength,,
GF2025_P6_Sph,0.5531636104835662,0.4269537274385414
RB2022_2_PreSprint,,
ZX2022_CB treated Replicate 3,0.5576736937883251,0.4387279690947748
RM2024_Intensity D6-2___3,,
WZ2023_Pe_025_10min,0.5471360775706886,0.4267902377658529
AS2011_Ratio H/L Normalized by Proteins RNAi_1,,
AST2020_anti-CD3+PDL2.1,,
KBE2022_Log2_Ex_34_U,0.558534072948688,0.43410935972032283
WZ2023_Pu_005_10min,0.5443231492051234,0.42659969841728734
AS2011_Ratio H/L RNAi_2_1,,
NJH2024_Sub9_HIIT_Mid,,
CK2022_9 40-1,0.5598400431809601,0.4323401436629873
KTGR2014_Ratio H L Normalized Rep1_Rapamycin_0_15,,
LG2023_GSK3α-1_intensity,,
WZ2023_Pu_025_30min,0.5451444771325801,0.42462551405095844
AH2018_SILAC_MR_2_X,,
HS2024_4_PD_T2,0.5685013429388103,0.4510172554475988
NJH2024_Sub4_HIIT_Pre,,
RB2022_2_RecoverySprint,,
AS2011_Ratio H/L Protein RNAi_1,,
RM2024_Intensity D2-1___2,,
CR2017_Ratio Replicate 1.4,0.5537178616470428,0.4166460145566197
FR2021_Norm.Intensity.B,,
RM2024_Intensity D6-2___1,,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.2-1,,
RB2022_5_PostSprint,,
EJN2021_3_Rest_Basal,,
CR2017_Ratio Replicate 1.3,0.548027752781632,0.4263112731865764
AS2011_Ratio H/L Normalized by Protein RNAi_2,,
KTGR2014_Ratio-Rapa 7 mins,,
AMK2021_120R_p1,,
AH2018_SILAC_3_X,,
JJ2018_Ratio M/L normalized pP3,,
AH2018_SILAC_M_2_N,0.5547060921570047,
HS2024_7_PD_T2,,0.41697684181617134
FSO2013_Ratio H/L normalized Rep1___1,0.5537652411247851,0.42350586743928426
AH2018_LFQ_1_C,0.557352277267206,
AS2011_Ratio H/L Normalized Inhi_1_3,,
KBE2022_Log2_Ex_28_T,0.5560554752474239,0.4316781816347734
HS2024_3_B_N1,0.5523029069729037,0.43325391795228496
RM2024_Intensity D4-2___3,,
WZ2023_Pe_025_30min,0.5457936701298169,0.43025237582712894
CK2022_11 40-1,0.5598592580985918,0.4329066421110403
CW2012_10 µM Erl/control Experiment 3 Replicate B,,
AH2018_SILAC_2_X,0.5542109766759249,
MV2014_Ratio H/M normalized A2___2 (2 min),,
AS2011_Ratio H/L RNAi_1_2,,
KS2014_Intensity E15_1,0.5567289191627235,
FSO2013_Ratio H/L normalized Rep2,0.5609522923234584,0.4112774632099133
WZ2023_Pu_005_20min,0.547207543423638,0.41744505879348637
NJH2024_Sub10_MICT_Post,,
RM2024_Intensity D2-3___1,,
CR2017_Ratio Replicate 1.5,0.5507372495619011,0.4160695732192948
CW2012_10 µM Gef/control Experiment 2 Replicate B,,
HS2024_7_B_T3,0.5488522573537545,0.41479761175756164
CKC2017_log2 normalized phosphoproteomics_60min_rep#1,,
AS2011_Ratio H/L RNAi_1,,
JC2019_Normalised_intensity_A_TiOx_Testis_sample_URO0059,,
AH2018_LFQ_M_1_C,0.558122940022939,
NJH2025_Sub7_MICT_Pre,,
SR2019_SKBR3_Biol_repl_2,,
HS2024_9_B_T2,0.556004520821795,0.42841309291346946
KTGR2014_Ratio-AA 7 mins,,
MV2014_Ratio L/H normalized B3___3 (5 min),,
HS2024_3_PD_T1,0.5607115399735465,0.4319542785572797
FSO2013_Ratio M/L normalized Rep3___2,0.5608045892924437,0.4432595226669189
SR2019_BT549_Biol_repl_3,,
RCJD2014_20min_mean,,
FR2021_Norm.Intensity.H,,
RB2022_2_PreStrength,,
DB2022_LFQ intensity L1.2,,
HS2024_4_B_N1,0.5492408193055599,0.44007076891270774
KTGR2014_Ratio H M Normalized Rep2_Rapamycin_0_15,,
CK2022_1 16-1,0.5525742871793345,0.42418879218312205
CK2022_1 200-1,0.5579300108625419,0.42651235564223244
PG2020_Intensity Mock_10h_D,,
SR2019_MCF10A_Biol_repl_2,,
JJ2018_Ratio M/L normalized pP2___2,,
HS2024_6_PD_T1,0.5491477039091276,0.42456066816371374
JVO2010_Ratio M/L Normalized by Protein ThymON - Log2 G1/S,,
RB2022_6_RecoveryEndurance,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt3b,,
EP2017_Mitotic R#2 normalized log2 ratio,0.5945001721232548,0.464608011665253
RCJD2014_5min_1,,
RM2024_Intensity D4-1___1,,
DL2023_24h-1,0.5576735924569366,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.1-1,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as2b,,
TM2022_S2.4h.C,,
SAS2015_PLX/AZD_Exp2,0.5605061276849789,
CR2017_Ratio Replicate 3.3,0.5443252164742691,0.42411849152499065
PG2020_Intensity 2h_C,,
VOI2024_Veh2 di,,
ZX2022_CB treated Replicate 2,0.558298432610022,0.44075097839631744
KBE2022_Log2_Ex_8_T,0.5549436185949155,0.4327256424538178
NJH2025_Sub10_MICT_Post,,
HS2024_6_I_T3,0.5554491748857816,0.4276392259506054
RN2012_L11,,
AS2011_Ratio H/L Normalized Inhi_2_2,,
IMM2018_normalised rep. int. Empty-1,,
HS2024_5_PD_T1,0.5609799404482889,
AH2018_LFQ_M_2_C,0.5521868712029425,
CK2022_3 40-1,0.55738173945849,0.43042368207060877
RBK2021_1260T Early,,
NJH2024_Sub4_HIIT_Post,,
HS2024_4_I_T1,0.5554880645930718,0.4290187023873882
YA2020_Reporter_intensity_Cancer_No.5,,
HH2022_Reporter intensity 8,0.5592662617489137,
ZQ2022_N2,,0.4297219200446122
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt1b,,
FSO2013_Ratio H/L normalized Rep3___3,,
AH2018_TMTMS3_2_N,,0.4326998668280532
EJN2021_5_Rest_Basal,,
NJH2025_Sub2_HIIT_Post,,
NJH2025_Sub1_MICT_Post,,
HS2024_9_B_T1,0.5546103131029961,0.4238093348917667
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt1a,,
JAW2011_Ratio H/L LS2_1,,
JVO2010_Log2 Ratio H/M Normalized aphidicolin,,
NJH2024_Sub6_HIIT_Pre,,
AH2018_SILAC_3_N,,
YA2020_Reporter_intensity_Normal_No.1,,
HS2024_3_B_T1,0.5598647311358722,0.4338632672490136
JJ2018_Ratio H/L normalized___2,,
RM2024_Intensity D0-2,,
MV2014_Ratio M/L normalized B1___2 (5 min),,
RB2022_7_PostStrength,,
RB2022_1_PostEndurance,,
CR2017_Ratio Replicate 3,0.5569556674821452,0.45207586383828735
SR2019_Hs578T_Biol_repl_3,,
MV2014_Ratio L/H normalized B3___1 (5 min),,
RBK2021_1244T Early,,
RB2022_3_PostSprint,,
NJH2024_Sub13_MICT_Mid,,
KTGR2014_Ratio-AA 2 mins,,
GF2025_P7_Sph,0.5537920236976812,0.42626553708588855
HS2024_8_I_T3,0.5486589163355187,
CF2017_EOC 3,,0.43134547747099233
LATM2013_Normalized Log2 Ratio (Medium/Light) Forward,,
HS2024_6_PD_T3,0.5493066860689209,0.4131253019193119
DL2023_12h-2,,
RM2024_Intensity D6-3___1,,
FS2019_Ctr1,,
WZ2023_Pu_010_20min,0.5461630710642321,0.4227460704030945
AS2011_Ratio H/L_3,,
CK2022_1 40-1,0.5573955163148913,0.43052699827862984
RNJ2017_Log2_ratio_Tsup:Trest_D1,,
CK2022_8 16-1,0.5510599384841739,0.41733083456110914
KS2014_Intensity N3,0.5586234537266135,0.4352885799457103
RB2022_4_RecoveryEndurance,,
RB2022_5_RecoveryEndurance,,
JAW2011_Ratio H/L LS1a_2,,
NJH2024_Sub12_HIIT_Mid,,
AH2018_LFQ_IT_1_N,0.5565909663050238,
FSO2013_Ratio H/M normalized Rep2,0.5528312301356528,0.44839069631576745
RAM2015_Log2 A,0.5482799732345746,0.4345003123462727
HS2024_8_PD_T1,0.5506754249515617,
JJ2018_Ratio H/L normalized pP2,,
CF2017_OSE 27,,
KS2014_Intensity E15_2,0.5571597620415925,
BS2014_Log2(Ratio H/L protein),,
PG2020_Intensity 8h_A,,0.43167451695084996
HS2024_7_I_T1,0.5497287340548636,0.41652788838585064
VOI2024_Veh3 di,,
RKK2015_TNF-α+SC-514/basal,,
SR2019_JIMT1_Biol_repl_1,,
HW2015_Ratio H/L normalized Exp2,,
HS2024_3_I_N1,0.553364640721395,0.4238725458941123
AH2018_SILAC_M_3_X,,
NJH2024_Sub9_HIIT_Post,,
AS2011_Ratio H/L RNAi_1_3,,
GRW2016_Ratio H/L normalized SILAC 1___2,,
NJH2025_Sub1_HIIT_Pre,,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.1-2,,
NJH2024_Sub4_HIIT_Mid,,
VOI2024_0.1uM 2 h_1 di,,
KBE2022_Log2_Ex_6_T,0.5547168011076802,0.4278042528280392
RM2024_Intensity D4-3___1,,
AH2018_LFQ_4_X,0.5559074594563489,
AS2011_Inhi 2_Ratio H/L normalized by corresponding protein level (H:TAL treatment; L: MA treatment),,
RB2022_8_PostEndurance,,
NJH2025_Sub4_MICT_Mid,,
YP2020_Intensity C30_R1_mult_log2,,
AST2020_anti-CD3.1,,
NJH2025_Sub4_HIIT_Post,,
EP2017_Untreated R#4 log2 ratio,0.5170106658857815,0.4350475606511278
HS2024_6_B_N1,0.5530176919893885,0.41759662447498913
KBE2022_Log2_Ex_27_T,0.5576873020896879,0.4355312100627402
CW2012_10 µM Gef/control Experiment 1 Replicate A,,
VOI2024_0.1uM 24 h_1 mono,,
AMK2021_120R_p5,,
AS2011_Ratio H/L Proteins,,
NJH2024_Sub7_HIIT_Post,,
NJH2015_TMT Subject 1 127_N/126 (Exercise/Basal) (normalized),,
AS2011_Ratio H/L RNAi_2_2,,
RB2022_7_RecoveryStrength,,
AH2018_SILAC_IT_3_X,,
JAW2011_Ratio H/L,,
PG2020_Intensity 10h_C,,0.4258419102989063
FSO2013_Ratio M/L normalized Rep2,0.569246516613028,0.41821400358280014
CP2009_Ratio H/M Normalized (50 nM dasatinib vs 5 nM dasatinib),,
HH2022_Reporter intensity 5,0.5607048360854834,
SR2019_HCC1954_Biol_repl_2,,
CK2022_14 40-1,0.5576226727474486,0.43017922594301244
RB2022_6_PreSprint,,
NJH2025_Sub12_MICT_Mid,,
PG2020_Intensity 4h_D,,0.42904752944440194
NJH2025_Sub2_MICT_Post,,
AH2018_LFQ_4_C,0.5566112973879663,
DL2023_control-1,0.5571068764121869,
AR2021_ALG 10 μM,0.5488283134634171,
JAW2011_Ratio H/L LS2_2,,
AH2018_SILAC_IT_3_N,,
EJN2021_4_Rest_Ins,,
RN2012_H05,0.5527278651969267,
NJH2024_Sub7_HIIT_Mid,,
GF2025_P2_Adh,0.5520447302706145,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as4b,,
RB2022_8_PostSprint,,
EJN2021_1_Rest_Ins,,
HH2022_Reporter intensity 3,0.5529347022183024,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt4b,,
AH2018_SILAC_IT_1_C,,
JW2021_After_3,,
GF2025_P8_Sph,0.5542347173229879,0.42502738860805916
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt4,,
JJ2018_Ratio M/L normalized pP2___1,,
AH2018_SILAC_2_N,0.5545782059749519,
CK2022_11 200-1,0.5659717761628983,0.4302958121577031
CK2022_12 200-1,0.5668613818972036,0.43203220125102165
AS2011_Ratio H/L Normalized by Protein RNAi_1,,
RM2024_Intensity D2-1___3,,
NJH2024_Sub1_MICT_Pre,,
HH2022_Reporter intensity 9,0.5528409834488652,
WZ2023_Su_010_20min,0.5461747626471303,0.42238692187826127
AH2018_TMTMS2_2_N,0.5521511757516488,
NJH2024_Sub13_MICT_Pre,,
KBE2022_Log2_Ex_41_U,0.5548333217798936,0.4297694416100414
NJH2015_TMT Subject 3 129_N/128_C (Exercise/Basal) (normalized),,
AH2018_TMTMS3_Pool,,0.4329375276278404
KS2014_Intensity N4,0.5520448357250567,0.43107966032309525
NJH2024_Sub1_HIIT_Post,,
MM2018_Ratio H/L replicate2,,
RM2024_Intensity D4-2___2,,
NJH2024_Sub13_HIIT_Pre,,
CF2017_OSE 26,,
CK2022_14 200-1,0.5591023325527519,0.42749727332755866
SR2019_Hs578T_Biol_repl_1,,
RB2022_7_PostSprint,,
TM2022_mock.4h.A,,
NJH2025_Sub12_HIIT_Pre,,
AH2018_TMTMS3_1_N,,0.4370107819197638
AST2020_anti-CD3+PDL2.2,,
PG2020_Intensity Mock_10h_A,,
JW2021_After_2,,
NJH2024_Sub2_MICT_Post,,
EJN2021_2_Rest_Ins,,
SR2019_LM2_Biol_repl_4,,
CP2009_Ratio H/M,,
JAW2011_Ratio H/L HS,,
CK2022_13 16-1,0.5515350427260449,0.4222981775557603
GF2025_P1_Adh,0.5558367380013892,
GF2025_P1_Sph,0.5550797226157723,
EJN2021_5_Ex_Basal,,
HS2024_7_I_T3,,0.42404367229748946
JJ2018_Ratio H/L normalized pP2___2,,
WZ2023_Pe_010_10min,0.545007069950448,0.43009930620638487
CF2017_EOC 1,,0.4361876751003791
CK2022_3 200-1,0.557267475933452,0.42655591907285706
AH2018_LFQ_IT_3_C,0.5551145332437699,
SR2019_Hs578T_Biol_repl_2,,
NJH2024_Sub12_HIIT_Post,,
JJ2018_Ratio H/L normalized pP1___2,,
MV2014_Ratio H/L normalized A1___2 (10 min),,
NJH2024_Sub10_MICT_Mid,,
NJH2024_Sub13_MICT_Post,,
BS2014_Log2(Ratio H/L normalized Rep_1),,
RB2022_3_RecoverySprint,,
NJH2025_Sub1_HIIT_Mid,,
RCJD2014_20min_2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt2,,
HS2024_6_PD_T2,0.5535020645380418,0.4280165009752788
HS2024_5_B_T1,0.555203908545014,
CW2012_10 µM Gef/control Experiment 2 Replicate A,,
DL2023_12h-3,0.5585493691685683,
SR2019_MDAMB231_Biol_repl_2,,
HS2024_3_B_T2,0.557859194687969,0.4269461066737635
RB2022_6_PreStrength,,
CK2022_2 40-1,0.5574732811681543,0.4296058784574455
RB2022_1_PostSprint,,
CK2022_4 200-1,0.5580308239694844,0.4264824981943609
JW2021_Before_2,,
TM2022_S2.12h.A,,
MV2014_Ratio L/M normalized B2___2 (30 min),,
CK2022_5 16-1,0.5498362672550372,0.41342734031294776
AR2021_ALG 1 μM,0.5537353595885601,
HS2024_4_B_T1,0.5557440138488827,0.41980869754243894
MV2014_Ratio M/H normalized A3___1 (10 min),,
SR2019_BT549_Biol_repl_4,,
EJN2021_1_Rest_Basal,,
NJH2025_Sub8_MICT_Post,,
RCJD2014_5min_3,,
CR2017_Ratio Replicate 3.2,0.5571989442137169,0.4349285810591601
FSO2012_Ratio -/+ 3-MB-PP1 exp. as3a,,
GF2025_P7_Adh,0.5551901813782223,0.4221489226573847
CK2022_9 16-1,0.5572949994465596,0.42848562187042066
NJH2024_Sub6_HIIT_Post,,
AMK2021_30R_p3,,
AS2011_Ratio H/L Normalized RNAi_2,,
RM2024_Intensity D0-2___2,,
KS2014_Intensity pY_N4,,
CK2022_13 200-1,0.5596434698469372,0.4269264056612149
AS2011_Ratio H/L Normalized_2,,
PG2020_Intensity 6h_D,,0.4358764932026662
CK2022_16 16-1,0.5513508708815601,0.42359718741941477
FS2019_db/db3,,
CK2022_15 40-1,0.5576535269919011,0.430062384127532
NJH2024_Sub9_MICT_Pre,,
BS2014_Log2(Ratio H/L unmodified peptide),,
WZ2023_Su_005_10min,0.545590991355224,0.4258980967744517
RM2009_Ratio M/L (M:15 min timepoint;L:0 min. timepoint),,
KBE2022_Log2_Ex_41_T,0.5523320353732817,0.4297828076666669
AMK2021_Ctrl_p1,,
AH2018_LFQ_IT_3_X,0.5541921716108904,
HS2024_5_PD_T3,,0.44035431239259576
AH2018_TMTMS3_3_X,,0.4337953587028915
FSO2012_Ratio -/+ 3-MB-PP1 exp. as2,,
KBE2022_Log2_Ex_40_U,0.5530070183486194,0.42183107175499435
AH2018_LFQ_M_1_N,0.5499891002794353,
KBE2022_Log2_Ex_27_U,0.5576016227735804,0.4347785055692049
HW2015_Ratio M/L normalized Exp3,,
RKK2015_TNF-α/IKKb(K44M),,
AH2018_SILAC_M_1_N,0.5567458966126613,
HW2015_Ratio M/L normalized Exp1,,
RB2022_5_RecoveryStrength,,
YP2020_Intensity P10_R1_mult_log2,,
RB2022_7_PreStrength,,
YA2020_Reporter_intensity_Normal_No.4,,
NJH2025_Sub13_HIIT_Pre,,
PG2020_Intensity CT_D,,0.4225587569610908
NJH2025_Sub9_MICT_Post,,
VOI2024_Veh1 mono,,
CK2022_12 16-1,0.557494536509804,0.4300832068586518
RN2012_L13,0.5493989191871859,
LG2023_Control-1_intensity,,
RM2024_Intensity D6-3___2,,
KBE2022_Log2_Ex_8_U,0.5565458793226126,
SR2019_SKBR3_Biol_repl_3,,
NJH2024_Sub1_MICT_Post,,
HS2024_3_I_T2,0.5590581487981173,0.44090268540960526
KTGR2014_Ratio M L Normalized Rep2_Rapamycin_0_15,,
RM2024_Intensity D0-3___3,,
HS2024_6_I_T2,0.5415542628355623,0.4098699110789937
CW2012_10 µM Erl/control Experiment 2 Replicate B,,
AS2011_Ratio H/L Protein Inhi_1,,
FSO2013_Ratio H/M normalized Rep2___1,0.5545112606626393,0.4463120516834031
GRW2016_Ratio M/L normalized SILAC 5a___2,,
CK2022_10 40-1,0.5598750445927604,0.4321582422805675
NJH2024_Sub12_HIIT_Pre,,
NJH2024_Sub8_MICT_Pre,,
RM2024_Intensity D0-1___1,,
LY2019_P3+,,0.45799058189870884
HH2022_Reporter intensity 6,0.5548141751879675,
RB2022_2_RecoveryStrength,,
KTGR2014_Ratio-AA 15 mins,,
AS2011_Ratio H/L Normalized RNAi_2_2,,
KS2014_Intensity pY_N3,,
MV2014_Ratio H/L normalized B1___2 (30 min),,
LY2019_P5-,,
HW2015_Ratio M/L normalized Exp2,,
SR2019_HCC1419_Biol_repl_1,,
AH2018_TMTMS2_3_X,0.5533103505752002,
GF2025_P3_Adh,0.5498320312042723,
SR2019_JIMT1_Biol_repl_2,,
AH2018_TMTMS2_1_C,0.5524796838114939,
RM2024_Intensity D0-1___2,,
LY2019_P4+,,0.45207819591337717
KBE2022_Log2_Ex_19_U,0.5496902744362017,0.42226665422214227
CKC2017_log2 normalized phosphoproteomics_0min_rep#1,,
RB2022_4_PostStrength,,
LG2023_GSK3α-3_intensity,,
YA2020_Reporter_intensity_Cancer_No.1,,
AST2020_Control,,
JAW2011_Ratio H/L LS1a,,
RCJD2014_5min_mean,,
NJH2015_iTRAQ Subject 4 114/115 (Exercise/Basal) (normalized),,
NJH2025_Sub1_MICT_Mid,,
TM2022_S2.12h.C,,
NJH2025_Sub9_MICT_Mid,,
CKC2017_log2 normalized phosphoproteomics_120min_rep#2,,
AS2011_Ratio H/L Normalized Inhi_1_2,,
FSO2013_Ratio M/L normalized Rep2___1,0.568840330736895,0.4183712352471212
LG2023_Control-2_intensity,,
NJH2024_Sub8_HIIT_Pre,,
KS2014_Intensity pY_N2,,
RB2022_5_RecoverySprint,,
RB2022_7_RecoverySprint,,
YA2020_Reporter_intensity_Normal_No.3,,
HS2024_8_B_T2,0.5502704694778431,
AH2018_LFQ_1_X,0.5567861737245705,
RM2024_Intensity D6-1___1,,
RCJD2014_10min_2,,
FR2021_Norm.Intensity.M,,
RM2024_Intensity D0-3___1,,
KS2014_Intensity N2,0.5590531747819898,0.43966863090154085
HH2022_Reporter intensity 1,0.5538674551801628,
HH2022_Reporter intensity 2,0.5538420527560575,
RM2024_Intensity D6-2___2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as1,,
RM2024_Intensity D2-3___2,,
YA2020_Reporter_intensity_Normal_No.5,,
SR2019_MCF7_Biol_repl_1,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as1a,,
HS2024_8_B_T1,,
NJH2025_Sub6_HIIT_Pre,,
RNJ2017_Log2_ratio_Tsup:Tstim_D1,,
EP2017_Untreated R#2 log2 ratio,0.5735257452004549,0.4490419374021383
SR2019_LM2_Biol_repl_3,,
RB2022_4_RecoveryStrength,,
CR2017_Ratio Replicate 2,0.5430085268851557,
CW2012_10 µM Erl/control Experiment 2 Replicate A,,
FSO2013_Ratio H/M normalized Rep3,0.5618394072927381,0.43263408779917184
AR2021_KD 72h,0.5613498624660724,
MV2014_Ratio H/M normalized B2___3 (5 min),,
KBE2022_Log2_Ex_18_U,0.5539494921437742,0.4291844035758126
AS2011_Ratio H/L Inhi_1_1,,
NJH2024_Sub8_MICT_Post,,
AH2018_TMTMS3_3_C,,0.42955084710001923
KBE2022_Log2_Ex_9_U,0.5505056975684317,0.4267139258359177
AH2018_SILAC_M_3_N,,
KBE2022_Log2_Ex_13_T,0.5556229666036616,0.42836627791002213
RM2024_Intensity D0-3,,
SR2019_SKBR3_Biol_repl_1,,
PG2020_Intensity Mock_10h_C,,0.40845695939920795
CF2017_OSE 29,,
YB2013_Ratio_H_L_Normalized_in_experiment_1,,
NJH2025_Sub1_HIIT_Post,,
DL2023_24h-2,0.555107557370898,
HS2024_7_B_N2,0.5452395813406389,0.41972171971568323
PG2020_Intensity 10h_A,,0.4237067318418168
RN2012_L12,,
MV2014_Ratio M/L normalized B1___3 (5 min),,
NJH2024_Sub8_MICT_Mid,,
AH2018_LFQ_IT_4_C,,
SAS2015_PLX/AZD_Exp1,,
FR2021_Norm.Intensity.A,,
FSO2013_Ratio H/M normalized Rep1___1,0.5503139389922801,0.44560542425081945
JW2015_Intensity cap2,,
BS2014_Log2(Ratio H/L normalized Rep_2),,
NJH2024_Sub6_MICT_Post,,
CK2022_8 40-1,0.5565075277450915,0.4272114909596046
RB2022_7_RecoveryEndurance,,
NJH2025_Sub12_HIIT_Post,,
EJN2021_4_Ex_Basal,,
TM2022_S2.12h.B,,
RN2012_L15,0.5573715936455399,
KS2014_Intensity pY_PV3,,
TM2022_S2.4h.B,,
PG2020_Intensity 4h_A,,0.42756313387724754
FSO2013_Ratio H/M normalized Rep2___2,0.5553637887592547,0.4338040381254898
TM2022_mock.4h.B,,
KBE2022_Log2_Ex_24_U,0.5550957179603657,0.4322988337659702
NJH2025_Sub13_MICT_Mid,,
KS2014_Intensity C3,0.5595702177523847,
RB2022_1_PreSprint,,
HS2024_4_I_N1,0.5585061538417544,
CK2022_7 200-1,0.5575087751512702,0.4229666876280079
CK2022_5 200-1,0.557282134503577,0.42271246850006117
CKC2017_log2 normalized phosphoproteomics_120min_rep#3,,
FSO2013_Ratio H/L normalized Rep2___1,0.5596981928995884,0.41148359729580847
NJH2024_Sub10_HIIT_Mid,,
RB2022_2_PostEndurance,,
AH2018_LFQ_2_C,0.5510984509485258,
AH2018_SILAC_MR_1_X,,
KTGR2014_Ratio H M Normalized Rep1_Rapamycin_0_15,,
IMM2018_normalised rep. int. Empty-2,,
RM2024_Intensity D4-1,,
KBE2022_Log2_Ex_25_U,0.5526894203934515,0.43273957510033206
AH2018_SILAC_3_C,,
EJN2021_5_Rest_Ins,,
VOI2024_0.1uM 24 h_3 di,,
RNJ2017_Log2_ratio_Tstim:Trest_D3,,
DB2022_LFQ intensity L2.1,,
FSO2013_Ratio H/M normalized Rep1,0.5487490479618886,0.4525240357648115
CK2022_4 16-1,0.5520351669006671,0.4227391053943936
AS2011_Ratio H/L,,
SR2019_MCF7_Biol_repl_4,,
EJN2021_2_Ex_Ins,,
AS2011_Ratio H/L Inhi_2_3,,
JAW2011_Ratio H/L LS1a_1,,
AH2018_LFQ_1_N,0.5561377353215422,
SAS2015_PLX/DMSO_Exp1,,
SFR2015_HL_log2_ratio_avg_c,0.5548825457731036,0.43337128142169157
JJ2018_Ratio M/L normalized pP2,,
NJH2024_Sub7_MICT_Mid,,
PG2020_Intensity 6h_B,,0.42924639501627787
FSO2013_Ratio H/L normalized Rep3,0.5618687232212626,0.41767392450463514
GRW2016_Ratio H/L normalized SILAC 2___2,,
RKK2015_IKKb(K44M)+TNF-α/TNF-α,,
JJ2018_Ratio M/L normalized,,
KTGR2014_Ratio-AA 30 mins,,
JW2021_After_1,,
NJH2025_Sub2_MICT_Mid,,
HS2024_6_B_N2,0.5574096516636665,0.4269502951420723
KBE2022_Log2_Ex_9_T,0.5540727136941402,0.43083210156538476
AH2018_SILAC_IT_2_N,,
AH2018_SILAC_IT_1_X,,
HW2015_Ratio H/L normalized Exp3,,
HS2024_7_PD_T1,,0.4194734515866318
UK2020_UA_2,,
RM2024_Intensity D2-1___1,,
GF2025_P10_Sph,0.5535673362783995,0.43820426220930253
WZ2023_Pe_025_20min,0.5465833643378786,0.4392408278154066
JVO2010_Log2 Ratio M/L Normalized aphidicolin,,
AH2018_LFQ_2_N,0.556386389208059,
HS2024_4_I_N2,0.5551133556880888,
AH2018_TMTMS2_3_N,0.5526800460393918,
RN2012_H06,0.5521423922965997,
AS2011_Inhi 1_Ratio H/L normalized by corresponding protein level (H:TAL treatment; L: MA treatment),,
HS2024_4_PD_T3,0.5462699221951629,0.42192381933179
WZ2023_Su_005_30min,0.5457032167222245,0.4142078306860358
SR2019_HCC1419_Biol_repl_4,,
JJ2018_Ratio H/M normalized___2,,
SR2019_JIMT1_Biol_repl_3,,
AS2011_Ratio H/L Protein,,
UK2020_HCM_3,,
NJH2024_Sub10_HIIT_Post,,
CR2017_Ratio Replicate 3.1,0.5564772348011151,0.4485272945211069
WZ2023_Su_025_10min,0.5484640866799959,0.42108583058005905
AH2018_LFQ_IT_4_X,,
CP2009_Ratio H/L,,
VOI2024_0.1uM 24 h_3 mono,,
RB2022_4_RecoverySprint,,
RM2024_Intensity D6-3,,
WZ2023_Su_005_20min,0.5460523274629839,0.41871589058474595
CW2012_10 µM Gef/control Experiment 1 Replicate B,,
SFR2015_HL_log2_ratio_avg_a,,0.44022935670831875
CW2012_10 µM Erl/control Experiment 3 Replicate A,,
RB2022_1_PreEndurance,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt3a,,
LG2023_GSK3α-2_intensity,,
EP2017_Pervanadate R#1 log2 ratio,0.5606097222808226,0.42771152337562857
NJH2025_Sub6_HIIT_Post,,
RB2022_6_RecoverySprint,,
KS2014_Intensity,0.5515403513999625,0.42952344916512547
MV2014_Ratio H/M normalized A2___1 (2 min),,
PG2020_Intensity 8h_D,,0.43037183443190924
LY2019_P7+,,
EP2017_Untreated R#1 normalized log2 ratio,0.5565640196378382,0.4209986820133408
RN2012_L10,,
PG2020_Intensity 4h_C,,0.4263794740177894
EP2017_Mitotic R#3 normalized log2 ratio,0.5955068473458265,0.4646226347325942
FSO2012_Ratio -/+ 3-MB-PP1 exp. as4,,
DB2022_LFQ intensity L1,,
KBE2022_Log2_Ex_24_T,0.5563950604005666,0.42913374785754443
RB2022_8_PostStrength,,
AH2018_SILAC_IT_2_X,,
HS2024_4_B_T3,0.558436775239079,0.4283359370186282
NJH2024_Sub2_HIIT_Post,,
HS2024_8_B_N2,,0.41742836397333
NJH2025_Sub8_HIIT_Pre,,
JJ2018_Ratio H/L normalized pP2___1,,
HS2024_8_I_T2,,0.4157761701496238
KBE2022_Log2_Ex_6_U,0.5554412672915618,0.4330556555609193
LATM2013_Normalized Log2 Ratio (Light/Medium) Reverse,,
CR2017_Ratio Replicate 1.1,0.5485160145692772,
CKC2017_log2 normalized phosphoproteomics_30min_rep#1,,
MV2014_Ratio M/H normalized B3___2 (30 min),,
CK2022_16 200-1,0.5599186849122116,0.42751159856594245
VOI2024_0.1uM 2 h_3 di,,
EP2017_Mitotic R#1 normalized log2 ratio,0.5905243104641448,0.4371215820741378
GF2025_P9_Sph,0.5508069021867302,0.4221625425443262
CK2022_6 200-1,0.5571124609119942,0.423244569366061
NJH2024_Sub7_MICT_Post,,
AH2018_TMTMS3_2_X,,0.43450937242476073
NJH2024_Sub8_HIIT_Post,,
DB2022_LFQ intensity R1,,
JW2015_Intensity cap3,,
SR2019_HCC1954_Biol_repl_1,,
HS2024_4_I_T2,,0.4525882501588056
NJH2024_Sub2_MICT_Mid,,
VOI2024_0.1uM 2 h_2 mono,,
CP2009_Ratio M/L Normalized (5 nM dasatinib vs Ctrl),,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as3b,,
HS2024_4_PD_T1,0.5501766903542091,0.4312160995868627
SAS2015_AZD/DMSO_Exp1,,
NJH2024_Sub1_MICT_Mid,,
IMM2018_normalised rep. int. CDK5L-3,,
HS2024_3_B_T3,0.5579310506479164,0.42162517546327866
MV2014_Ratio L/H normalized A3___2 (2 min),,
NJH2025_Sub13_MICT_Pre,,
SR2019_MDAMB231_Biol_repl_3,,
GRW2016_Ratio H/L normalized SILAC 4___1,,
MM2018_Ratio H/L replicate1,,
PG2020_Intensity 2h_D,,0.4230472477567095
EP2017_Untreated R#3 normalized log2 ratio,0.5321082488220148,0.45018323845941083
MV2014_Ratio M/H normalized A3___3 (10 min),,
NJH2024_Sub7_HIIT_Pre,,
JAW2011_Ratio H/L LS2,,
CK2022_8 200-1,0.5570387753386862,0.4223820895326313
KS2014_Intensity pY_C4,,
CR2017_Ratio Replicate 3.5,0.558603476592266,0.43993016271496804
RB2022_7_PostEndurance,,
NJH2025_Sub4_HIIT_Pre,,
CKC2017_log2 normalized phosphoproteomics_90min_rep#3,,
TM2022_mock.12h.A,,
JJ2018_Ratio H/L normalized pP1,,
EP2017_Pervanadate R#2 normalized log2 ratio,0.5687874810202783,0.4303631786668949
AS2011_Ratio H/L Normalized by Protein (Unnormalized),,
KS2014_Intensity pY_E5_4,,
RM2024_Intensity D4-3___2,,
CKC2017_log2 normalized phosphoproteomics_15min_rep#1,,
AH2018_SILAC_2_C,0.5551321332614986,
AS2011_RNAi 2_Ratio H/L normalized by corresponding protein level (H: shPlk1; L: shEg5),,
HS2024_7_I_N1,0.5457307003012793,0.413310349600498
KBE2022_Log2_Ex_29_T,0.5542476596591325,0.42923310264177855
HS2024_7_I_T2,,0.42062764307822986
AS2011_Ratio H/L Normalized RNAi_2_3,,
CW2012_10 µM Gef/control Experiment 3 Replicate B,,
HS2024_6_B_T2,0.5511199748732403,0.43381593504346266
AMK2021_45I_p5,,
CW2012_10 µM Erl/control Experiment 1 Replicate A,,
SAS2015_PLX/DMSO_Exp2,0.5598171147072238,
EJN2021_1_Ex_Basal,,
FR2021_Intensity.M,,
RB2022_2_PostSprint,,
AH2018_SILAC_MR_3_N,,
MV2014_Ratio H/L normalized B1___3 (30 min),,
CF2017_FTE 13,,
PG2020_Intensity CT_C,,0.416946797019918
ZCP2016_Ratio H/L Rep 1,,
FS2019_db/db2,,
KS2014_Intensity pY_PV4,,
KBE2022_Log2_Ex_39_U,0.5529975126860117,0.4298713006664444
EP2017_Untreated R#3 log2 ratio,0.5327501549013713,0.4506020057280788
RB2022_2_PostStrength,,
AS2011_Ratio H/L Normalized_1,,
MV2014_Ratio M/H normalized A3___2 (10 min),,
CR2017_Ratio Replicate 3.4,0.549856815598151,0.4520608716576443
HS2024_8_PD_T2,0.5540664465894344,
FS2019_Ctr2,,
RB2022_6_PreEndurance,,
FR2021_Norm.Intensity.G,,
NJH2025_Sub9_HIIT_Post,,
CKC2017_log2 normalized phosphoproteomics_0min_rep#3,,
RM2024_Intensity D4-3,,
HS2024_8_B_N1,,0.41944630497572694
NJH2025_Sub10_MICT_Mid,,
KBE2022_Log2_Ex_15_U,0.5566526303127468,0.4377115017143113
AS2011_Ratio H/L Normalized Inhi_2,,
RKK2015_TNF-α/SC-514,0.5565568562530969,
RB2022_3_PreSprint,,
CR2017_Ratio Replicate 2.3,0.5459998486871582,
RM2009_Ratio M/L Normalized by Corresponding Protein Level (M:15 min timepoint;L:0 min. timepoint),,
CP2009_Ratio H/L Normalized (50 nM dasatinib vs Ctrl),,
GF2025_P4_Adh,0.5546279600022289,
YA2020_Reporter_intensity_Normal_No.2,,
YP2020_Intensity P30_R2_mult_log2,,
NJH2025_Sub13_MICT_Post,,
HS2024_4_B_N2,0.5529121823836107,0.4366702839646092
HS2024_3_PD_T3,0.5546493204880916,0.4301062708582629
AMK2021_120R_p3,,
MV2014_Ratio L/H normalized A3___3 (2 min),,
NJH2025_Sub10_HIIT_Pre,,
FR2021_Intensity.G,,
RAM2015_Log2 C,0.5464229779381068,0.4242553676473563
AS2011_Ratio H/L Proteins Inhi_1,,
FSO2013_Ratio H/M normalized Rep1___3,,
AH2018_LFQ_M_2_N,0.5490348576148449,
MV2014_Ratio M/L normalized A1___3 (2 min),,
KBE2022_Log2_Ex_40_T,0.5529895795336445,0.42192450247020374
CK2022_2 16-1,0.5518763929875723,0.4232570344282879
RAM2015_Log2 B,0.5419406299972355,0.4262734827598213
YP2020_Intensity C10_R1_mult_log2,,
FSO2013_Ratio M/L normalized Rep1___2,0.5500202948740118,0.4240018540625763
NJH2025_Sub8_MICT_Pre,,
EJN2021_4_Rest_Basal,,
YB2013_Ratio_H_L_Normalized_in_experiment_2,,
JJ2018_Ratio H/M normalized pP3___1,,
VOI2024_Veh2 mono,,
HS2024_6_B_T1,0.5570019064635989,0.4386486866719342
UK2020_HCM_5,,
NJH2025_Sub10_HIIT_Post,,
VOI2024_0.1uM 2 h_3 mono,,
JW2015_Intensity pre3,,
AS2011_Ratio H/L Normalized Inhi_2_1,,
DL2023_24h-3,0.5572070738806901,
HS2024_7_PD_T3,0.5514667528303475,0.43437382538002905
PG2020_Intensity Mock_10h_B,,
WZ2023_Su_025_30min,0.5467156145541945,0.4263899804858426
AH2018_LFQ_4_N,0.550650422976072,
CR2017_Ratio Replicate 1.2,0.5648478810314481,0.4520909794822336
AS2011_Ratio H/L Normalized by Proteins,,
RB2022_6_RecoveryStrength,,
HS2024_8_I_N1,,0.4160537374908212
AMK2021_Ctrl_p3,,
AS2011_Ratio H/L Protein Inhi_2,,
HH2022_Reporter intensity 7,0.5561046878930163,
AH2018_SILAC_M_1_X,0.5550691991887774,
RB2022_7_PreEndurance,,
VOI2024_0.1uM 24 h_2 di,,
DL2023_control-2,,
LY2019_P6+,,0.4202372326496855
DB2022_LFQ intensity R2,,
GF2025_P6_Adh,0.5565874280723204,0.4275452604287963
VOI2024_Veh1 di,,
AS2011_Ratio H/L RNAi_2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as3,,
VOI2024_Veh3 mono,,
HS2024_5_I_T2,0.5533222607922288,
NJH2025_Sub7_HIIT_Mid,,
MV2014_Ratio H/L normalized B1___1 (30 min),,
RM2009_Ratio H/L (H:60 min timepoint;L:0 min. timepoint),,
RB2022_6_PostSprint,,
KTGR2014_Ratio H L Normalized Rep2_Rapamycin_0_15,,
AS2011_Ratio H/L Inhi_1,,
AS2011_Ratio H/L Normalized RNAi_1_2,,
AH2018_TMTMS3_2_C,,0.4312650019025644
SR2019_Hs578T_Biol_repl_4,,
RB2022_8_PreStrength,,
KS2014_Intensity C5,0.5559685595308662,
RM2024_Intensity D0-1,,
CW2012_10 µM Gef/control Experiment 3 Replicate A,,
YP2020_Intensity P30_R1_mult_log2,,
NJH2025_Sub2_HIIT_Pre,,
RB2022_3_RecoveryEndurance,,
RNJ2017_Log2_ratio_Tstim:Trest_D2,,
GF2025_P9_Adh,0.5538083866608526,0.42721516874624077
RB2022_3_PostStrength,,
TM2022_S2.8h.A,,
AS2011_Ratio H/L RNAi_1_1,,
AS2011_Ratio H/L Normalized by Proteins RNAi_2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt1,,
AS2011_Ratio H/L Normalized by Protein Inhi_1,,
NJH2025_Sub2_MICT_Pre,,
MV2014_Ratio L/M normalized A2___3 (10 min),,
MV2014_Ratio H/M normalized A2___3 (2 min),,
HS2024_4_B_T2,0.5569302182122327,0.42842860774746466
SR2019_BT549_Biol_repl_1,,
AH2018_LFQ_M_4_N,0.5518650967713681,
NJH2024_Sub8_HIIT_Mid,,
PG2020_Intensity 8h_B,,0.4323477786136097
AH2018_LFQ_2_X,0.5489619087006848,
PG2020_Intensity 2h_B,,
AS2011_Ratio H/L Proteins RNAi_1,,
RB2022_4_PostSprint,,
KS2014_Intensity E15_3,0.5587581909282513,
GF2025_P3_Sph,0.5519312207687391,
DB2022_LFQ intensity L2,,
MV2014_Ratio H/L normalized A1___1 (10 min),,
AH2018_SILAC_1_C,0.556503384248052,
NJH2024_Sub1_HIIT_Pre,,
FSO2013_Ratio M/L normalized Rep2___2,0.5497216623514423,0.423468581700845
NJH2015_TMT Subject 4 130_N/129_C (Exercise/Basal) (normalized),,
AS2011_Ratio H/L RNAi_2_3,,
AH2018_SILAC_IT_1_N,,
KTGR2014_Ratio H M Normalized Rep2_AA_starvation_0_15,,
RB2022_4_PreEndurance,,
JJ2018_Ratio M/L normalized pP1,,
CR2017_Ratio Replicate 2.4,0.554069861400693,0.4167913589170982
ZQ2022_N1,,0.4296291621427585
LY2019_P6-,,
RM2024_Intensity D2-3,,
UK2020_HCM_1,,
JW2015_Intensity pre2,,
KTGR2014_Ratio M L Normalized Rep1_AA_starvation_0_15,,
RM2024_Intensity D2-1,,
NJH2025_Sub12_MICT_Post,,
MV2014_Ratio H/M normalized B2___2 (5 min),,
RN2012_L14,0.5577369364213522,
AH2018_LFQ_3_N,0.556763166832104,
RKK2015_TNF-α/IKKb,,
SFR2015_HL_log2_ratio_std_b,0.5550678408065084,0.4660946118186211
UK2020_UA_1,,
KBE2022_Log2_Ex_13_U,0.5571919485573108,
AS2011_Ratio H/L Normalized Inhi_1,,
RNJ2017_Log2_ratio_Tsup:Trest_D2,,
RB2022_1_RecoverySprint,,
CKC2017_log2 normalized phosphoproteomics_120min_rep#1,,
JJ2018_Ratio H/L normalized pP3,,
CK2022_7 40-1,0.556646946564789,0.4280088816212217
AS2011_Ratio H/L Inhi_1_3,,
NJH2025_Sub10_HIIT_Mid,,
KTGR2014_Ratio H L Normalized Rep2_AA_starvation_0_15,,
JAW2011_Ratio H/L LS1b_1,,
PG2020_Intensity 4h_B,,0.4277814652515641
SR2019_BT549_Biol_repl_2,,
RM2024_Intensity D4-2,,
DB2022_LFQ intensity R2.2,,
JJ2018_Ratio H/L normalized,,
RB2022_5_PostEndurance,,
HS2024_5_PD_T2,,0.43581958725864833
WZ2023_Su_025_20min,0.5472856779688725,0.4224582248547815
RM2024_Intensity D2-2___1,,
IMM2018_normalised rep. int. CDK5L-2,,
LY2019_P8-,,0.45213338735295217
JVO2010_Ratio H/M Normalized by Protein ThymON - Log2 G2,,
CKC2017_log2 normalized phosphoproteomics_15min_rep#3,,
FSO2013_Ratio H/L normalized Rep1,0.5534968854548454,0.42095490057032625
NJH2024_Sub2_HIIT_Pre,,
CKC2017_log2 normalized phosphoproteomics_60min_rep#2,,
CK2022_13 40-1,0.5575830746999391,0.4297837266963923
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt4a,,
RN2012_H02,,
PG2020_Intensity 10h_D,,0.4213016144897454
RB2022_8_PreEndurance,,
HS2024_3_B_N2,0.5538318411390862,0.4282533424562856
EJN2021_4_Ex_Ins,,
AS2011_Ratio H/L Normalized by Protein,,
EJN2021_1_Ex_Ins,,
EP2017_Pervanadate R#3 log2 ratio,0.5677522963671232,0.43484097550302264
FSO2013_Ratio M/L normalized Rep1___3,,
NJH2025_Sub4_HIIT_Mid,,
RCJD2014_5min_2,,
RB2022_6_PostStrength,,
AH2018_SILAC_MR_3_C,,
AH2018_LFQ_M_4_C,0.5574866396071002,
NJH2024_Sub4_MICT_Pre,,
AS2011_Ratio H/L Normalized Inhi_1_1,,
DL2023_12h-1,,
MV2014_Ratio L/M normalized B2___1 (30 min),,
DB2022_LFQ intensity L1.1,,
NJH2025_Sub6_MICT_Pre,,
NJH2025_Sub6_MICT_Post,,
CKC2017_log2 normalized phosphoproteomics_60min_rep#3,,
RN2012_H04,0.5489792477346769,
CK2022_6 40-1,0.5563013395019082,0.4279208937586008
DB2022_LFQ intensity R2.1,,
KBE2022_Log2_Ex_42_U,0.5545683497292847,0.4357744931264456
LY2019_P3-,,0.4405121275964562
FR2021_Intensity.A,,
EJN2021_3_Ex_Ins,,
MV2014_Ratio M/L normalized A1___1 (2 min),,
WZ2023_Pe_005_30min,0.5454329637455299,0.43402681516998864
HS2024_8_PD_T3,0.5532812417236308,
EJN2021_3_Ex_Basal,,
AST2020_Control.1,,
JW2015_Intensity cap1,,
PG2020_Intensity CT_A,,
FS2019_Ctr3,,
WZ2023_Pu_025_20min,0.54843489229638,0.427087793141896
NJH2025_Sub4_MICT_Post,,
JVO2010_Ratio H/M Normalized by Protein Noco3h - Log2 Late S,,
GF2025_P10_Adh,0.552779991939005,0.42415762062837736
RB2022_1_RecoveryStrength,,
SR2019_HCC1954_Biol_repl_4,,
FR2021_Norm.Intensity.N,,
HS2024_5_B_N1,,0.4319192173142344
FSO2013_Ratio H/M normalized Rep3___3,,
AH2018_TMTMS2_2_C,0.5522957754233219,
RB2022_4_PreSprint,,
DB2022_Intensity R2,,
AH2018_TMTMS2_Pool,,0.43151019682935493
HS2024_8_I_N2,,0.41836169181615995
RB2022_3_RecoveryStrength,,
NJH2024_Sub6_HIIT_Mid,,
AH2018_SILAC_M_1_C,0.5568345766143316,
LY2019_P8+,,
RB2022_2_RecoveryEndurance,,
JJ2018_Ratio H/M normalized pP2___1,,
JAW2011_Ratio H/L HS_1,,
RB2022_3_PostEndurance,,
KS2014_Intensity pY_PV1,,
JAW2011_Ratio H/L LS1b_2,,
SR2019_MCF7_Biol_repl_2,,
NJH2015_TMT Subject 2 128_N/127_C (Exercise/Basal) (normalized),,
AS2011_Ratio H/L Normalized RNAi_1_1,,
AH2018_LFQ_M_4_X,0.5568096855033259,
NJH2024_Sub6_MICT_Pre,,
JJ2018_Ratio M/L normalized pP1___2,,
YP2020_Intensity C30_R2_mult_log2,,
NJH2024_Sub9_HIIT_Pre,,
AS2011_Ratio H/L Normalized Inhi_2_3,,
RM2024_Intensity D0-1___3,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt3,,
KBE2022_Log2_Ex_28_U,0.5545949461003267,0.42854964708942905
GRW2016_Ratio H/L normalized SILAC 1___1,,
CF2017_FTE 17,,0.4263384608632392
LY2019_P2-,,0.43099780368858426
AH2018_LFQ_IT_1_X,0.5548592646323179,
JJ2018_Ratio H/L normalized pP3___1,,
RB2022_8_RecoveryStrength,,
WZ2023_Pe_005_20min,0.5478182060937037,0.4420356360846098
AST2020_Control.2,,
NJH2025_Sub6_MICT_Mid,,
RCJD2014_10min_1,,
FSO2013_Ratio H/L normalized Rep2___3,,
JVO2010_Ratio M/L Normalized by Protein Noco3h - Log2 G1,,
HS2024_3_I_T1,0.5631198620435223,0.43833259506329236
FSO2012_Ratio -/+ 3-MB-PP1 exp. as2a,,
CK2022_4 40-1,0.5571814022154966,0.43000634966855733
SR2019_MCF10A_Biol_repl_4,,
KS2014_Intensity pY_C5,,
NJH2025_Sub4_MICT_Pre,,
NJH2024_Sub9_MICT_Post,,
CF2017_OSE 28,,0.42753472739310794
HS2024_5_B_T2,0.5523459268182493,
HS2024_6_I_T1,,0.41112299776326106
HS2024_5_B_T3,0.553880325428567,
JJ2018_Ratio H/M normalized pP1___1,,
KBE2022_Log2_Ex_36_U,0.558599933812963,0.43638837687426923
AH2018_TMTMS3_3_N,,0.4356006580458655
SR2019_HCC1419_Biol_repl_2,,
FR2021_Intensity.N,,
AS2011_Ratio H/L Inhi_2_1,,
AH2018_SILAC_MR_1_C,,
NJH2024_Sub1_HIIT_Mid,,
NJH2025_Sub8_HIIT_Mid,,
EP2017_Mitotic R#3 log2 ratio,0.5923786630544756,0.4630096876740436
KBE2022_Log2_Ex_36_T,0.5588835073618484,0.432739759686377
NJH2025_Sub6_HIIT_Mid,,
WZ2023_Pu_005_30min,0.5459535504467624,0.4011972193796268
KS2014_Intensity C2,0.5538020488030114,
FSO2013_Ratio H/L normalized Rep1___2,0.5528542205821328,0.41953533845959295
RM2024_Intensity D2-2,,
KBE2022_Log2_Ex_42_T,0.5535480123716539,0.43111899865214526
CK2022_9 200-1,0.5661697130813743,0.43092264080871834
GRW2016_Ratio H/L normalized SILAC 2___1,,
JJ2018_Ratio H/M normalized pP3___2,,
DB2022_LFQ intensity R1.1,,
CK2022_10 200-1,0.5653282947688887,0.43028791632558977
NJH2024_Sub9_MICT_Mid,,
JAW2011_Ratio H/L_2,,
HS2024_7_I_N2,0.5473425099115186,
RBK2021_1332T Late,,
LY2019_P1-,,0.43154639071587875
RKK2015_TNF-α/basal.1,,
RKK2015_TNF-α/TNF-α+SC-514,,
CR2017_Ratio Replicate 2.5,0.5617579816117013,0.441459356888581
HS2024_3_I_T3,0.5576812775017791,0.4334517981222224
CKC2017_log2 normalized phosphoproteomics_90min_rep#2,,
AS2011_Ratio H/L Normalized RNAi_1,,
KS2014_Intensity E15_4,0.5562148926212036,
ZQ2022_C3,,0.44758951632166494
EJN2021_3_Rest_Ins,,
YP2020_Intensity P10_R2_mult_log2,,
MV2014_Ratio H/L normalized A1___3 (10 min),,
NJH2025_Sub1_MICT_Pre,,
KBE2022_Log2_Ex_39_T,0.5529956545445762,0.42728093421296914
FSO2013_Ratio H/M normalized Rep3___2,0.5508575179622562,0.42978590248701753
RM2024_Intensity D6-2,,
EP2017_Untreated R#1 log2 ratio,0.5573387093209184,0.42121318092163623
RKK2015_SC-514/basal,0.5573936001298211,
RM2024_Intensity D6-1___3,,
WZ2023_Pu_010_10min,0.5495536578891808,0.43568300007666994
NJH2025_Sub9_HIIT_Mid,,
SR2019_SKBR3_Biol_repl_4,,
HS2024_5_I_T3,0.5652911537930946,
KS2014_Intensity N1,0.561898853044217,0.4395962968950101
NJH2024_Sub12_MICT_Post,,
TM2022_S2.8h.C,,
CR2017_Ratio Replicate 1,0.5489270227560464,
AS2011_RNAi 1_Ratio H/L normalized by corresponding protein level (H: shPlk1; L: shEg5),,
CKC2017_log2 normalized phosphoproteomics_30min_rep#3,,
JJ2018_Ratio H/M normalized pP3,,
AH2018_SILAC_MR_2_C,,
LATM2013_Log2 Ratio (Medium/Light) Forward,,
PG2020_Intensity 2h_A,,
NJH2024_Sub6_MICT_Mid,,
NJH2025_Sub13_HIIT_Post,,
AH2018_SILAC_MR_3_X,,
JJ2018_Ratio H/M normalized___1,,
RCJD2014_15min_2,,
AS2011_Ratio H/L_2,,
AS2011_Ratio H/L Normalized,,
RN2012_H03,,
HS2024_5_B_N2,,0.440559075066532
HS2024_5_I_N1,,0.4288099016083769
HS2024_6_I_N1,0.550206708474304,0.43638219366464026
AR2021_KD 48h,0.5581750482322453,
FR2021_Intensity.B,,
RB2022_3_PreEndurance,,
HS2024_5_I_T1,0.5545732803825486,
NJH2024_Sub10_MICT_Pre,,
SR2019_LM2_Biol_repl_2,,
AST2020_anti-CD3,,
SR2019_MDAMB231_Biol_repl_1,,
RM2024_Intensity D2-3___3,,
WZ2023_Pe_005_10min,0.5469898977945481,0.43624038280155847
KBE2022_Log2_Ex_29_U,0.5540627853013548,0.42855187478267126
HS2024_7_B_T1,0.5499952915697367,0.41200308168095906
AH2018_LFQ_M_2_X,0.5505269154990263,
AH2018_LFQ_IT_4_N,,
CK2022_15 200-1,0.5600046939089689,0.4272530635168873
RM2024_Intensity D4-1___2,,
JJ2018_Ratio H/M normalized,,
JJ2018_Ratio M/L normalized pP3___1,,
KBE2022_Log2_Ex_34_T,0.559064625665399,0.43656859640668333
CKC2017_log2 normalized phosphoproteomics_0min_rep#2,,
LY2019_P2+,,0.4225960382524657
LATM2013_Log2 Ratio (Light/Medium) Reverse,,
CK2022_2 200-1,0.5581188048325604,0.42656336252094146
AS2011_Ratio H/L Protein RNAi_2,,
MV2014_Ratio L/H normalized A3___1 (2 min),,
WZ2023_Su_010_30min,0.5486315124614582,0.4169413657316746
RN2012_H01,,
KTGR2014_Ratio-Rapa 2 mins,,
EJN2021_2_Rest_Basal,,
KS2014_Intensity pY_E5_3,,
MM2018_Ratio H/L replicate 3,,
EP2017_Pervanadate R#1 normalized log2 ratio,0.5605523766107828,0.42767060938212614
HS2024_8_B_T3,,
YA2020_Reporter_intensity_Cancer_No.3,,
KBE2022_Log2_Ex_44_U,0.5548638149258237,0.4273473863395726
WZ2023_Pe_010_20min,0.5465460458605231,0.43771504543703704
KS2014_Intensity pY_C6,,
AS2011_Ratio H/L Normalized_3,,
RCJD2014_15min_mean,,
RB2022_3_PreStrength,,
NJH2015_iTRAQ Subject 3 116/117 (Exercise/Basal) (normalized),,
RCJD2014_10min_mean,,
KS2014_Intensity C1,0.5629178819183903,
FSO2013_Ratio H/M normalized Rep3___1,0.5631045042030631,0.4315144639612451
AH2018_SILAC_M_3_C,,
RKK2015_TNF-α+IKKb/TNF-α,,
RM2024_Intensity D0-3___2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt2a,,
AH2018_SILAC_M_2_C,0.5552597356516443,
AH2018_SILAC_M_2_X,0.5539845453010683,
KTGR2014_Ratio-Rapa 15 mins,,
RM2024_Intensity D4-2___1,,
KBE2022_Log2_Ex_15_T,0.5561779325197234,0.4308834574497694
VOI2024_0.1uM 24 h_1 di,,
WZ2023_Su_010_10min,0.5459087855520246,0.4296983433578063
PG2020_Intensity 6h_C,,0.4341876662126138
JVO2010_Ratio M/L Normalized by Protein Noco45 - Log2 mitosis,,
JJ2018_Ratio M/L normalized pP1___1,,
AH2018_LFQ_M_3_N,0.5576222009376821,
VOI2024_0.1uM 24 h_2 mono,,
AH2018_TMTMS2_3_C,0.5523604956779825,
CK2022_15 16-1,0.5520778523336921,0.4241426559066793
CK2022_3 16-1,0.551409091781142,0.424941809223822
LY2019_P4-,,0.43215563071293234
FSO2013_Ratio H/L normalized Rep3___2,0.5536909883276239,0.42688808944681406
KS2014_Intensity pY_PV2,,
HS2024_3_I_N2,0.5540010709627935,0.4258984111178106
GF2025_P8_Adh,0.5590884989043037,0.44136738801242953
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.2-2,,
GF2025_P5_Sph,0.5534432103912112,
CK2022_10 16-1,0.5569902441410083,0.4264107501204307
KTGR2014_Ratio H L Normalized Rep1_AA_starvation_0_15,,
VOI2024_0.1uM 2 h_2 di,,
NJH2015_TMT Pool 131/130_C (Exercise/Basal) (normalized),,
NJH2024_Sub2_HIIT_Mid,,
AMK2021_45I_p3,,
NJH2024_Sub13_HIIT_Mid,,
DB2022_LFQ intensity R1.2,,
DB2022_Intensity R1,,
NJH2024_Sub12_MICT_Mid,,
KTGR2014_Ratio M L Normalized Rep1_Rapamycin_0_15,,
UK2020_HCM_4,,
SAS2015_AZD/DMSO_Exp2,0.5551901247780898,
IMM2018_normalised rep. int. CDK5L-1,,
DB2022_LFQ intensity L2.2,,
KTGR2014_Ratio H M Normalized Rep1_AA_starvation_0_15,,
EP2017_Mitotic R#1 log2 ratio,0.5864508320578627,0.43591938524811397
EJN2021_2_Ex_Basal,,
RM2009_Ratio H/L Normalized by Corresponding Protein Level (H:60 min timepoint;L:0 min. timepoint),,
KTGR2014_Ratio-Rapa 30 mins,,
CKC2017_log2 normalized phosphoproteomics_90min_rep#1,,
CF2017_FTE 16,,
AR2021_L41 10 μM,0.5527215329775043,
CF2017_EOC 2,,0.43043689959295595
RB2022_6_PostEndurance,,
AH2018_SILAC_1_N,0.5567038290526503,
NJH2024_Sub10_HIIT_Pre,,
AS2011_Ratio H/L Inhi_1_2,,
UK2020_HCM_6,,
RB2022_7_PreSprint,,
NJH2024_Sub2_MICT_Pre,,
HS2024_3_PD_T2,0.5613951897885487,0.4254046933834336
CK2022_6 16-1,0.5507072917431316,0.4144041904333618
ZX2022_CB treated Replicate 1,0.55750738254934,0.43900032149413165
BS2014_Log2(Ratio H/L normalized Rep_3),,
TM2022_mock.12h.C,,
GRW2016_Ratio M/L normalized SILAC 5a___1,,
HH2022_Reporter intensity 0,0.5532656310028068,
RM2024_Intensity D2-2___2,,
JC2019_Normalised_intensity_B_TiOx_Testis_sample_URO0126,,
RB2022_1_PreStrength,,
JJ2018_Ratio H/M normalized pP2___2,,
AH2018_TMTMS2_2_X,0.5524477135856863,
AR2021_L41 1 μM,0.5526979015508937,
JJ2018_Ratio H/M normalized pP1___2,,
AH2018_TMTMS2_1_N,0.5519163896976843,
NJH2025_Sub10_MICT_Pre,,
JVO2010_Ratio H/M Normalized by Protein Noco45 - Log2 early S,,
ZX2022_Control Replicate 3,0.5565411846139386,0.43694548707627706
KS2014_Intensity C4,0.5585544293633758,0.43483006411183334
AS2011_Ratio H/L Inhi_2,,
KBE2022_Log2_Ex_18_T,0.5522155652035204,0.42098907923662965
NJH2025_Sub9_MICT_Pre,,
RCJD2014_20min_1,,
MV2014_Ratio H/M normalized B2___1 (5 min),,
FSO2013_Ratio M/L normalized Rep2___3,,
JC2019_Normalised_intensity_C_TiOx_Testis_sample_URO0158,,
SR2019_MCF10A_Biol_repl_3,,
HS2024_7_B_T2,0.5464154690254,0.41300748012070976
SAS2015_PLX/DMSO_Exp3,0.5636025990068014,
AMK2021_Ctrl_p5,,
NJH2025_Sub2_HIIT_Mid,,
AH2018_LFQ_M_3_C,0.5575082761802953,
CKC2017_log2 normalized phosphoproteomics_15min_rep#2,,
YA2020_Reporter_intensity_Cancer_No.2,,
FSO2013_Ratio H/M normalized Rep2___3,,
RB2022_8_PreSprint,,
AH2018_SILAC_IT_3_C,,
WZ2023_Pu_025_10min,0.5451534039880366,0.4305051903707021
RM2024_Intensity D2-2___3,,
AS2011_Ratio H/L_1,,
RCJD2014_10min_3,,
FSO2013_Ratio M/L normalized Rep3___1,0.56021841368648,0.4478804503312044
SR2019_JIMT1_Biol_repl_4,,
YP2020_Intensity C10_R2_mult_log2,,
ZCP2016_Ratio H/L Rep 2,,
CF2017_EOC 4,,
JJ2018_Ratio H/L normalized pP1___1,,
WZ2023_Pe_010_30min,0.5477236325580155,0.4388809904350885
MV2014_Ratio L/M normalized B2___3 (30 min),,
AH2018_LFQ_IT_3_N,0.5545589058603076,
KS2014_Intensity C6,0.5563068214317518,
ZQ2022_N3,,0.4312665605838474
HW2015_Ratio H/L normalized Exp1,,
CK2022_12 40-1,0.560339891684979,0.43373921273416366
NJH2024_Sub7_MICT_Pre,,
ZX2022_Control Replicate 1,0.5569015910014535,0.4376513434959532
JJ2018_Ratio H/M normalized pP1,,
CK2022_16 40-1,0.5576100304212964,0.4300465447423442
AH2018_SILAC_IT_2_C,,
CK2022_5 40-1,0.5562574929094007,0.4264490760433181
AH2018_LFQ_3_X,0.5563509505570664,
UK2020_UA_3,,
LY2019_P7-,,
GF2025_P5_Adh,0.5551244383083113,
RB2022_1_PostStrength,,
JAW2011_Ratio H/L LS1b,,
FSO2013_Ratio H/L normalized Rep3___1,0.5623338234188188,0.4178451802687694
SR2019_HCC1954_Biol_repl_3,,
CR2017_Ratio Replicate 2.2,0.5377970286094615,
VOI2024_0.1uM 2 h_1 mono,,
MV2014_Ratio L/M normalized A2___1 (10 min),,
RNJ2017_Log2_ratio_Tsup:Tstim_D3,,
CK2022_11 16-1,0.5567101352604823,0.4265472371487447
ZQ2022_C1,,0.4372845253973598
CR2017_Ratio Replicate 2.1,0.5564946309314093,
PG2020_Intensity CT_B,,
JJ2018_Ratio M/L normalized___2,,
AH2018_SILAC_MR_1_N,,
KS2014_Intensity pY_E5_1,,
JW2021_Before_3,,
NJH2015_iTRAQ Subject 2 117/116 (Exercise/Basal) (normalized),,
MV2014_Ratio M/H normalized B3___3 (30 min),,
FS2019_db/db1,,
NJH2025_Sub9_HIIT_Pre,,
JAW2011_Ratio H/L_1,,
RCJD2014_20min_3,,
AH2018_LFQ_3_C,0.556595289220513,
JJ2018_Ratio M/L normalized pP3___2,,
AMK2021_45I_p1,,
NJH2025_Sub8_HIIT_Post,,
AH2018_LFQ_M_3_X,0.5500569649062418,
YA2020_Reporter_intensity_Cancer_No.4,,
KS2014_Intensity pY_E5_2,,
FSO2013_Ratio H/L normalized Rep1___3,,
GF2025_P4_Sph,0.5481064161241581,
RB2022_2_PreEndurance,,
JW2021_Before_1,,
KBE2022_Log2_Ex_25_T,0.5546749267908705,0.4319685589312736
AS2011_Ratio H/L Normalized by Proteins Inhi_2,,
MV2014_Ratio L/M normalized A2___2 (10 min),,
JJ2018_Ratio M/L normalized___1,,
FR2021_Intensity.H,,
CK2022_14 16-1,0.5511241281836089,0.42395572924521163
AST2020_anti-CD3+PDL2,,
MV2014_Ratio M/L normalized B1___1 (5 min),,
KBE2022_Log2_Ex_19_T,0.5575156760251694,0.4330748527072363
KS2014_Intensity pY_N1,,
RB2022_1_RecoveryEndurance,,
FSO2013_Ratio H/M normalized Rep1___2,0.556321501671104,0.43796906965849
HS2024_8_I_T1,0.5462524050355629,
NJH2015_iTRAQ Subject 1 115/114 (Exercise/Basal) (normalized),,
EP2017_Mitotic R#2 log2 ratio,0.5903837509331348,0.4624498032179866
AH2018_TMTMS2_1_X,0.552467331593972,
KTGR2014_Ratio M L Normalized Rep2_AA_starvation_0_15,,
ZCP2016_Ratio H/L Rep 3,,
AS2011_Ratio H/L Normalized RNAi_1_3,,
SR2019_MCF10A_Biol_repl_1,,
NJH2025_Sub8_MICT_Mid,,
EJN2021_5_Ex_Ins,,
HS2024_6_I_N2,0.548202918853821,0.4241717860028139
HH2022_Reporter intensity 4,0.5521111473764839,
RBK2021_1326T Late,,
TM2022_mock.12h.B,,
NJH2024_Sub12_MICT_Pre,,
RCJD2014_15min_3,,
MV2014_Ratio L/H normalized B3___2 (5 min),,
LG2023_Control-3_intensity,,
JJ2018_Ratio H/L normalized pP3___2,,
CF2017_FTE 15,,
HS2024_4_I_T3,0.5678036428042462,0.4493200640988138
AH2018_SILAC_1_X,0.5549530300157781,
PG2020_Intensity 10h_B,,0.4236834710611836
AH2018_TMTMS3_1_X,,0.4328218572022418
CF2017_FTE 14,,
NJH2024_Sub13_HIIT_Post,,
RM2024_Intensity D6-3___3,,
NJH2025_Sub7_HIIT_Pre,,
RBK2021_1259T Early,,
RKK2015_IKK+TNF-α/IKKb,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as1b,,
PG2020_Intensity 6h_A,,0.43443975913889865
SR2019_HCC1419_Biol_repl_3,,
KBE2022_Log2_Ex_14_T,0.5553620980232069,0.42953555753015366
EP2017_Untreated R#2 normalized log2 ratio,0.5727958524434679,0.4487257582092083
RM2024_Intensity D0-2___1,,
DB2022_Intensity L1,,
LY2019_P5+,,0.4351816756830606
HS2024_5_I_N2,,0.43253587997248927
SAS2015_PLX/AZD_Exp3,0.5654159757994454,
EP2017_Pervanadate R#2 log2 ratio,0.5689883863852678,0.4304141721467284
AS2011_Ratio H/L Normalized RNAi_2_1,,
